On December 18, Gelonghui reported that APT Medical Inc. (688617.SH) announced that on December 17, 2024, its wholly-owned subsidiary Hunan APT Medical Instruments Co., Ltd. obtained a medical instrument registration certificate for a product named "Disposable Magnetic Electric Positioning Pressure Monitoring Pulse Electric Field Ablation Catheter." This product is used in medical Institutions and is meant to be used in conjunction with Shanghai Hongtong Industrial Co., Ltd.'s cardiac pulse electric field ablation device (Model: PFG-micro1, Software Release Version V1). It must be used alongside the disposable cardiac pulse electric field ablation catheter produced by the company, intended for the treatment of drug-resistant, recurrent, symptomatic paroxysmal atrial fibrillation. The disposable cardiac pulse electric field ablation catheter is used for pulmonary vein and vestibular ablation, while this product serves as a supplemental ablation. This product works with the three-dimensional cardiac electrophysiological mapping system produced by Shanghai Hongtong Industrial Co., Ltd. (Model: HT-9000Pro, Software Release Version V2) to provide positional information of the catheter within the heart.
惠泰医疗(688617.SH):一次性使用磁电定位压力监测脉冲电场消融导管取得医疗器械注册证
APT Medical Inc. (688617.SH): The disposable magnetic positioning pressure monitoring pulsed electric field ablation catheter has obtained the medical instruments registration certificate.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.